Metformin alleviated EMT and fibrosis after renal ischemia-reperfusion injury in rats

Renal Failure

Volumn 38, Issue 4, 2016, Pages 614-621

  Wang, Min ^a   Weng, Xiaodong ^a   Guo, Jia ^a   Chen, Zhiyuan ^a   Jiang, Guanjun ^a   Liu, Xiuheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Epithelial matrix transformation; fibrosis; ischemia reperfusion injury; metformin; renal

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMMUNOREACTIVE INSULIN; INTERLEUKIN 6; METFORMIN; TOSYLARGININE METHYL ESTER; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HISTOPATHOLOGY; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANIMAL; COMPLICATION; DRUG EFFECTS; FIBROSIS; KIDNEY; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; KIDNEY; MALE; METFORMIN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84959210817     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2016.1149770     Document Type: Article

References (25)

1. Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 2008; 74: 860-866.
2. Lin SL, Li B, Rao S, et al. Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci USA. 2010; 107: 4194-4199.
3. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008; 214: 199-210.
4. Guarino M, Tosoni A, Nebuloni M. Direct contribution of epithelium to organ fibrosis: Epithelial-mesenchymal transition. Hum Pathol. 2009; 40: 1365-1376.
5. Jiang T, Huang B, Chen PS, et al. Epithelial-mesenchymal transition of renal tubules: Divergent processes of repairing in acute or chronic injury? Med Hypotheses. 2013; 81: 73-75.
6. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs. 2007; 185: 222-231.
7. Wang Q, Usinger W, Nichols B, et al. Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 2011; 4: 4.
8. Yeh YC, Wei WC, Wang YK, et al. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis. Am J Pathol. 2010; 177: 1743-1754.
9. Zeng R, Han M, Luo Y, et al. Role of Sema4C in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. Nephrol Dial Transplant. 2011; 26: 1149-1156.
10. El Messaoudi S, Rongen GA, de Boer RA, et al. The cardioprotective effects of metformin. Curr Opin Lipidol. 2011; 22: 445-453.
11. Lin A, Sekhon C, Sekhon B, et al. Attenuation of ischemia-reperfusion injury in a canine model of autologous renal transplantation. Transplantation. 2004; 78: 654-659.
12. Seo-Mayer PW, Thulin G, Zhang L, et al. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. Am J Physiol Renal Physiol. 2011; 301: F1346-F1357.
13. Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, et al. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis. Cell Cycle. 2010; 9: 4461-4468.
14. Xiao H, Ma X, Feng W, et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res. 2010; 87: 504-513.
15. Lee MJ, Feliers D, Mariappan MM, et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007; 292: F617-F627.
16. de Oliveira CP, Stefano JT, de Siqueira ER, et al. Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis. Hepatol Res. 2008; 38: 159-165.
17. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med. 2003; 349: 2326-2333.
18. Guo G, Morrissey J, McCracken R, et al. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol. 1999; 277: F766-F772.
19. Meldrum KK, Misseri R, Metcalfe P, et al. TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R1456-R1464.
20. Dong R, Wang Q, He XL, et al. Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz J Med Biol Res. 2007; 40: 1071-1078.
21. Chaudhuri V, Zhou L, Karasek M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: A potential role in skin fibrogenesis. J Cutan Pathol. 2007; 34: 146-153.
22. Sato M, Muragaki Y, Saika S, et al. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest. 2003; 112: 1486-1494.
23. Misseri R, Rink RC, Meldrum DR, et al. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res. 2004; 119: 149-159.
24. Peairs A, Radjavi A, Davis S, et al. Activation of AMPK inhibits inflammation in MRL/Lpr mouse mesangial cells. Clin Exp Immunol. 2009; 156: 542-551.
25. Lee JH, Kim JH, Kim JS, et al. AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol. 2013; 304: F686-F697.